temozolomide has been researched along with sincalide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Deng, S; Guo, M; Li, Y; Liu, Y; Peng, Y; Qi, S; Ren, J; Shu, S; Yi, G; Zhao, L | 1 |
| Li, Y; Liu, Q; Peng, G; Qin, C; Su, J | 1 |
1 review(s) available for temozolomide and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for temozolomide and sincalide
| Article | Year |
|---|---|
miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Kaplan-Meier Estimate; Mice, Nude; Microarray Analysis; MicroRNAs; Multidrug Resistance-Associated Proteins; RNA, Messenger; Sincalide; Temozolomide; Time Factors; Transfection; Xenograft Model Antitumor Assays | 2018 |
Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments.
Topics: Biomarkers; DNA-Binding Proteins; Ferroptosis; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mitochondria; Mitochondrial Proteins; Reactive Oxygen Species; Sincalide; Temozolomide | 2022 |